Home › Cancer (all types) › Alaska › Anchorage
Cancer (all types) clinical trials in Anchorage, AK
4 studies for Cancer (all types) are looking for participants at sites in and around Anchorage (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
RecruitingPhase 3
- Alaska Women's Cancer Care, Anchorage
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
RecruitingPhase 2
- Alaska Womens Cancer Care ( Site 0037), Anchorage
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Providence Alaska Medical Center, Anchorage
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Anchorage Associates in Radiation Medicine, Anchorage
- Alaska Breast Care and Surgery LLC, Anchorage
- Alaska Oncology and Hematology LLC, Anchorage
- and 3 more
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX122 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Washington, DC60 studies
- Philadelphia, PA60 studies
- Durham, NC59 studies
- Chicago, IL52 studies
- Seattle, WA50 studies
- Atlanta, GA50 studies
- Arlington, VA48 studies
Other studies in Anchorage
- Non-Small Cell Lung Cancer8 studies
- Ovarian Cancer7 studies
- Breast Cancer7 studies
- Lung Cancer6 studies
- Endometrial Cancer5 studies
- Prostate Cancer5 studies
- Pancreatic Cancer4 studies
- Esophageal Adenocarcinoma3 studies
- Stomach Cancer3 studies
- Esophageal Cancer3 studies
- Colorectal Cancer3 studies
- Acute Biphenotypic Leukemia3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.